Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#51 / 120 Total
INDP - Indaptus Therapeutics Inc - Stock Price Chart
TickerINDP [NASD]
CompanyIndaptus Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap6.84MEPS (ttm)-1.62
P/E-EPS this Y50.93%
Forward P/E-EPS next Y20.25%
PEG-EPS past 5Y57.27%
P/S-EPS next 5Y26.86%
P/B1.30EPS Q/Q21.80%
Dividend-Sales Q/Q-
Insider Own19.56%Inst Own12.78%
Insider Trans0.00%Inst Trans1.44%
Short Float1.02%EarningsMar 13/b
Analyst Recom1.00Target Price2.00
Avg Volume420.10K52W Range0.42 - 3.10
May-08-25 08:00AM Indaptus Therapeutics Founder and Chief Scientific Officer Dr. Michael Newman Named Chair and Expert Speaker at 6th Annual Cytokine-Based Drug Development Summit (GlobeNewswire)
Mar-25-25 08:00AM Indaptus Therapeutics Chief Medical Officer Roger Waltzman, M.D., M.B.A. to Moderate Panel at CMO360 Summit (GlobeNewswire) +7.96%
Mar-20-25 08:00AM Indaptus Therapeutics Reports New Data Demonstrating Successful Broad Immune System Activation in Weekly Dosing Trial of Decoy20 (GlobeNewswire)
Mar-18-25 08:00AM Indaptus Therapeutics Initiates Phase 1 Combination Study of Decoy20 with PD-1 Checkpoint Inhibitor Tislelizumab (GlobeNewswire)
Mar-13-25 07:30AM Indaptus Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
Mar-12-25 04:15PM Registration Is Now Open For Tribe Public's Webinar Event Keys To The Kingdom: Unlocking The Power Of Your Immune System Featuring Indaptus Therapeutics' CEO On Monday, March 17, 2025 (GlobeNewswire)
Mar-04-25 08:00AM Indaptus Therapeutics Expands Patent Portfolio in China, Japan, and Israel, Strengthening its Intellectual Property for Infectious Disease and Cancer Treatments (GlobeNewswire)
Feb-25-25 08:00AM Indaptus Therapeutics' Chief Scientific Officer Dr. Michael Newman to Present at the 10th Annual Innate Killer Summit (GlobeNewswire)
Feb-05-25 08:00AM Indaptus Therapeutics Receives Approval from Health Canada to Expand Clinical Trial of Decoy20 (GlobeNewswire) -9.49%
Jan-13-25 08:00AM Indaptus Therapeutics, Inc. Announces $2.25 Million Private Placement Priced At-The-Market Under Nasdaq Rules (GlobeNewswire)
Indaptus Therapeutics, Inc. is a pre-clinical biotechnology company. It engages in the development of a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. The firm created patented treatment methods and associated patented compositions for attenuation and killing of non-pathogenic, Gram-negative bacteria. The company was founded by Michael James Newman on February 24, 2021 and is headquartered in New York, NY.
MNDR - Mobile health Network Solutions - Stock Price Chart
TickerMNDR [NASD]
CompanyMobile health Network Solutions
CountrySingapore
IndustryHealth Information Services
Market Cap6.22MEPS (ttm)-0.35
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.60EPS next 5Y-
P/B16.15EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own45.29%Inst Own8.73%
Insider Trans0.00%Inst Trans0.37%
Short Float2.85%Earnings-
Analyst Recom1.00Target Price64.00
Avg Volume1.14M52W Range1.29 - 21.68
Mobile-health Network Solutions is an investment holding company, which engages in the provision of telehealth solutions through MaNaDr platform. The platform seeks to offer users the ability to teleconsult with doctors and prescribe and deliver medication at their doorsteps. It operates through the Telemedicine and Other Services and Sale of Medicine and Medical Devices. The Telemedicine and Other Services segment includes providing teleconsultation services to patients from both private and public sector. The Sale of Medicine and Medical Devices segment focuses on selling prescription drugs, non-prescription drugs, and healthcare products to clinics and end customers offline and online. The company was founded by Tung Yeng Siaw and Pui Pui Teoh on July 28, 2016 and is headquartered in Singapore.
ACDC - ProFrac Holding Corp - Stock Price Chart
TickerACDC [NASD, RUT]
CompanyProFrac Holding Corp
CountryUSA
IndustryOil & Gas Equipment & Services
Market Cap636.71MEPS (ttm)-1.49
P/E-EPS this Y-21.43%
Forward P/E-EPS next Y54.41%
PEG-EPS past 5Y-13.22%
P/S0.29EPS next 5Y57.47%
P/B0.64EPS Q/Q-3189.47%
Dividend-Sales Q/Q3.23%
Insider Own92.59%Inst Own8.31%
Insider Trans0.42%Inst Trans1.26%
Short Float36.33%EarningsMay 07/b
Analyst Recom3.80Target Price7.10
Avg Volume656.72K52W Range4.00 - 9.75
ProFrac Holding Corp. engages in the provision of hydraulic fracturing, proppant production, and other completion services. It operates through the following segments: Stimulation Services, Proppant Production, Manufacturing, and Other. The Stimulation Services segment owns a fleet of mobile hydraulic fracturing units and other auxiliary equipment that generates revenue by providing stimulation services to customers. The Proppant Production segment focuses on the provision of proppant to oilfield service providers and exploration and production companies. The Manufacturing segment is involved in the sale of products such as horsepower pumps, valves, piping, swivels, large-bore manifold systems, and fluid ends. The Other segment refers to Flotek Industries and Livewire Power, LLC. The company was founded in 2016 and is headquartered in Willow Park, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wilks Farris10% OwnerFeb 26 '25Buy6.93338,7562,347,5791,316,534Feb 28 04:57 PM
Wilks MatthewExecutive ChairmanFeb 26 '25Buy6.93288,7562,001,079288,756Feb 27 04:23 PM
THRC Holdings, LP10% OwnerSep 12 '24Buy6.17353,6352,181,92879,197,549Sep 16 04:43 PM
THRC Holdings, LP10% OwnerSep 10 '24Buy6.44262,8531,692,77378,843,915Sep 11 04:46 PM
THRC Holdings, LP10% OwnerSep 09 '24Buy6.252,15413,46278,581,062Sep 11 04:46 PM
CTXR - Citius Pharmaceuticals Inc - Stock Price Chart
TickerCTXR [NASD]
CompanyCitius Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap6.87MEPS (ttm)-5.80
P/E-EPS this Y69.96%
Forward P/E0.54EPS next Y172.49%
PEG-EPS past 5Y20.90%
P/S-EPS next 5Y-
P/B0.08EPS Q/Q10.20%
Dividend-Sales Q/Q-
Insider Own5.74%Inst Own6.73%
Insider Trans0.00%Inst Trans-28.11%
Short Float8.16%EarningsFeb 14/a
Analyst Recom1.00Target Price5.67
Avg Volume314.99K52W Range0.68 - 26.25
Citius Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus on oncology, anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. Its products include I/ONTAK, Mino-Lok, Halo-Lido, Mino-Wrap, and Novecite. The company was founded by Ralph Montrone on January 23, 2007 and is headquartered in Cranford, NJ.
ALXO - Alx Oncology Holdings Inc - Stock Price Chart
TickerALXO [NASD, RUT]
CompanyAlx Oncology Holdings Inc
CountryUSA
IndustryBiotechnology
Market Cap24.57MEPS (ttm)-2.61
P/E-EPS this Y35.50%
Forward P/E-EPS next Y16.69%
PEG-EPS past 5Y-32.29%
P/S-EPS next 5Y25.68%
P/B0.21EPS Q/Q18.81%
Dividend-Sales Q/Q-
Insider Own36.33%Inst Own59.15%
Insider Trans0.06%Inst Trans-4.42%
Short Float18.06%EarningsMay 08/b
Analyst Recom1.33Target Price4.55
Avg Volume786.94K52W Range0.46 - 17.56
ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications. The company was founded by Corey Goodman, Jaume Pons, and K. Christopher Garcia in March 2015 and is headquartered in South San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Pinto ShellySVP, FINANCE AND CAOFeb 19 '25Sale1.1555063387,352Feb 21 04:25 PM
Pons JaumePRESIDENT & CSOFeb 19 '25Sale1.151,3261,525579,388Feb 21 04:23 PM
Lettmann JasonCHIEF EXECUTIVE OFFICERFeb 19 '25Sale1.152,1592,483170,270Feb 21 04:20 PM
Pinto ShellyInterim CFOJan 06 '25Sale1.802,2213,99887,902Jan 08 04:10 PM
Pinto ShellyInterim CFODec 30 '24Sale1.581,4262,25390,123Jan 02 04:46 PM
AMRK - A-Mark Precious Metals Inc - Stock Price Chart
TickerAMRK [NASD, RUT]
CompanyA-Mark Precious Metals Inc
CountryUSA
IndustryCapital Markets
Market Cap476.73MEPS (ttm)1.49
P/E13.93EPS this Y-28.36%
Forward P/E8.56EPS next Y22.84%
PEG4.10EPS past 5Y78.46%
P/S0.04EPS next 5Y3.40%
P/B0.79EPS Q/Q-271.77%
Dividend3.86%Sales Q/Q14.50%
Insider Own27.43%Inst Own62.09%
Insider Trans0.00%Inst Trans-7.78%
Short Float9.17%EarningsMay 07/a
Analyst Recom1.50Target Price40.00
Avg Volume290.04K52W Range20.60 - 47.39
A-Mark Precious Metals, Inc. engages in the trading of gold, silver, platinum, and palladium bullion numismatic coins, and related products. It operates through the following segments: Wholesale Trading and Ancillary Services, Direct-to-Consumer, and Secured Lending. The Wholesale Trading and Ancillary Services segment is involved in the distribution and purchasing of metal products from sovereign and private mints. The Direct-to-Consumer segment provides access to a multitude of products through its wholly owned subsidiaries. The Secured Lending segment includes coin and precious metal dealers, investors, and collectors. The company was founded by Steven C. Markoff on April 9, 1965 and is headquartered in El Segundo, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BENJAMIN JEFFREY DDirectorSep 20 '24Sale43.6560,0002,618,965664,198Sep 24 02:47 PM
Wittmeyer Michael R.DirectorSep 19 '24Option Exercise17.8774,8421,337,427367,377Sep 23 03:11 PM
Wittmeyer Michael R.DirectorSep 20 '24Option Exercise17.8710,975196,123303,510Sep 23 03:11 PM
Wittmeyer Michael R.DirectorSep 19 '24Sale44.0074,8423,292,851292,535Sep 23 03:11 PM
Wittmeyer Michael R.DirectorSep 20 '24Sale43.3010,975475,187292,535Sep 23 03:11 PM
PSIG - PS International Group Ltd - Stock Price Chart
TickerPSIG [NASD]
CompanyPS International Group Ltd
CountryHong Kong
IndustryIntegrated Freight & Logistics
Market Cap10.13MEPS (ttm)-0.23
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.26EPS next 5Y-
P/B0.24EPS Q/Q86.06%
Dividend-Sales Q/Q-
Insider Own84.39%Inst Own0.79%
Insider Trans0.00%Inst Trans44.47%
Short Float1.31%Earnings-
Analyst Recom-Target Price-
Avg Volume205.87K52W Range0.38 - 12.05
PS International Group Ltd. engages in providing logistics and supply chain solutions. The company was founded on September 12, 2023 and is headquartered in Hong Kong.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chun Kit TsuiChief Financial OfficerMay 06 '25Proposed Sale0.42266,000111,720May 05 08:09 AM
MCRB - Seres Therapeutics Inc - Stock Price Chart
TickerMCRB [NASD]
CompanySeres Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap60.73MEPS (ttm)-9.99
P/E-EPS this Y-
Forward P/E-EPS next Y-833.58%
PEG-EPS past 5Y5.33%
P/S-EPS next 5Y-
P/B1.20EPS Q/Q168.26%
Dividend-Sales Q/Q-
Insider Own26.90%Inst Own23.04%
Insider Trans-1.46%Inst Trans-
Short Float11.98%EarningsMay 07/b
Analyst Recom2.60Target Price13.33
Avg Volume75.65K52W Range7.18 - 30.60
May-08-25Downgrade Chardan Capital Markets Buy → Neutral $6
Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Young Teresa L.See RemarksFeb 18 '25Sale0.813,3382,70497,536Feb 19 08:11 PM
Henn Matthew R.See RemarksFeb 18 '25Sale0.813,9533,20484,443Feb 19 08:10 PM
Shaff Eric D.CEO and PresidentFeb 18 '25Sale0.8112,72610,314192,039Feb 19 08:08 PM
DesRosier ThomasChief Legal Officer and EVPFeb 18 '25Sale0.814,3003,485142,456Feb 19 08:07 PM
von Moltke LisaSee RemarksFeb 18 '25Sale0.814,4163,57939,875Feb 19 08:05 PM
TRAW - Traws Pharma Inc - Stock Price Chart
TickerTRAW [NASD]
CompanyTraws Pharma Inc
CountryUSA
IndustryBiotechnology
Market Cap7.47MEPS (ttm)-113.92
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y42.51%
P/S32.48EPS next 5Y-
P/B-EPS Q/Q550.61%
Dividend-Sales Q/Q0.00%
Insider Own26.20%Inst Own10.60%
Insider Trans0.00%Inst Trans0.52%
Short Float1.95%EarningsMar 31/b
Analyst Recom1.00Target Price6.00
Avg Volume79.54K52W Range1.36 - 19.44
Traws Pharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. It focuses on discovering and developing small molecule drug candidates to treat cancer. The company was founded by Ramesh Kumar and E. Premkumar Reddy on December 22, 1998 and is headquartered in Newtown, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CAUTREELS WERNERChief Executive OfficerFeb 18 '25Option Exercise0.0196,348963104,348Feb 19 06:23 PM
STKH - Steakholder Foods Ltd ADR - Stock Price Chart
TickerSTKH [NASD]
CompanySteakholder Foods Ltd ADR
CountryIsrael
IndustryPackaged Foods
Market Cap2.37MEPS (ttm)-11.48
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y1.21%
P/S237.33EPS next 5Y-
P/B0.51EPS Q/Q-362.55%
Dividend-Sales Q/Q-100.00%
Insider Own-Inst Own5.40%
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom1.00Target Price250.00
Avg Volume39.28K52W Range2.76 - 23.10
Steakholder Foods Ltd. is an international deep-tech food company, which engages in the provision of production technology and associated supplies needed to commercially produce structured alternative protein products. The firm is also involved in developing and selling two types of 3D-printing production machines and developing plant-based products that aim to replicate the complex textures of traditional meats such as beef steaks, white fish, shrimp, and eel. The company was founded by Arik Kaufman, Yaron Kaiser, Sharon Fima, and Omri Schanin on July 22, 1992 and is headquartered in Rehovot, Israel.
123456789101112